ChromoGenics Q2 2023: Weak on topline but better margins due better cost control and yield in production - Redeye

Weak on topline but better margins due better cost control and yield in production.

Länk till analysen i sin helhet: https://www.redeye.se/research/928635/chromogenics-q2-2023-weak-on-topline-but-better-margins-due-better-cost-control-and-yield-in-production?utm_source=finwire&utm_medium=RSS